Trials / Completed
CompletedNCT01270555
Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults
Efficacy Of Bupropion SR For Attention Deficit Hyperactivity Disorder (ADHD) In Adults With Recent Past or Current Substance Use Disorders
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The investigators propose to conduct an open study to evaluate the efficacy and tolerability of Bupropion SR using clinically relevant doses in ADHD adults with a recent history of or current substance use disorders. We hypothesize that Bupropion SR will be effective in treating ADHD in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupropion SR | 100mg capsules Initial dosing 100mgSR every morning, to be titrated to 200mgSR twice daily maximum |
Timeline
- Start date
- 1999-05-01
- Primary completion
- 2001-07-01
- First posted
- 2011-01-05
- Last updated
- 2013-03-08
- Results posted
- 2011-02-25
Source: ClinicalTrials.gov record NCT01270555. Inclusion in this directory is not an endorsement.